Muntlig fråga om främjande av den finska vaccinproduktionen (Merja Kyllönen vänst)

This procedure is an oral question regarding the support and development of vaccine production within Finland. It focuses on strengthening national pharmaceutical capabilities to ensure a more secure supply of medicines and vaccines, particularly in response to challenges posed by the coronavirus and other infectious diseases. This affects the Finnish pharmaceutical industry, research institutions, and healthcare strategy, aiming to improve national health security and self-sufficiency in medical manufacturing.